197 filings
Page 7 of 10
6-K
i12l8
30 Mar 17
Affimed Reports Financial Results for Fourth Quarter
12:00am
6-K/A
fvgukza22mbg5356k4c
9 Feb 17
Current report (foreign) (amended)
12:00am
6-K
npg213u18e06
8 Feb 17
Current report (foreign)
12:00am
6-K
2j2dlobqlw854d 7v
25 Jan 17
Current report (foreign)
12:00am
424B5
gaje5j7sz2vxwbcihiv
24 Jan 17
Prospectus supplement for primary offering
12:00am
424B5
m8jzz7p5onzy9avb 1mp
19 Jan 17
Prospectus supplement for primary offering
12:00am
6-K
1e7t6w
11 Jan 17
Affimed Provides Update on NK-Cell Immuno-Oncology Platform
12:00am
6-K
53jdm7x8 n2
5 Jan 17
Transforming Immuno - Oncology Using Next - Generation Immune Cell Engagers Corporate Presentation January 2017
12:00am
6-K
dqwa42a46e2
4 Jan 17
Agreement Brings Together MD Anderson’s Natural Killer Cell and Affimed’s Antibody-based Technologies
12:00am
424B5
5xp sksaj36x9
15 Dec 16
Prospectus supplement for primary offering
12:00am
6-K
02w63eo6tk
6 Dec 16
Current report (foreign)
12:00am
6-K
4xc9z fxx
2 Nov 16
Index to Condensed Consolidated Financial Statements
12:00am
6-K
d9y85
10 Aug 16
Index to Condensed Consolidated Financial Statements
12:00am
6-K
nej698zj
1 Jul 16
Current report (foreign)
12:00am
6-K
t6x22dpq727od
22 Jun 16
Current report (foreign)
12:00am
6-K
hx7opt
23 May 16
Affimed Announces Annual General Meeting of Shareholders
12:00am
6-K
4catpk0sabfobfv7mq
18 May 16
Index to Condensed Consolidated Financial Statements
12:00am
6-K
ae03un0l eijozqdb
30 Mar 16
Affimed Reports Financial Results for Fourth Quarter
12:00am